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Abstract - Adenomatoid tumor of the epididymis is a rare benign neoplasm of mesothelial origin, mostly localized in the 
epididymis. It is usually presented as an indolent, painless scrotal enlargement. Immunohistochemically it is characterized 
by strong positivity for calretinin and epithelial markers, while tumor marker values are within the reference ranges. In this 
paper, two cases of 28- and 37-year-old men with adenomatoid tumors of the epididymis are described. In both, the tumor 
was presented as an indolent, slowly growing palpable mass in the epididymis. Tumor markers were in the normal range, 
digital examination found painless scrotal enlargement, while ultrasound showed a nonhomogeneous tumor. Immunohis-
tochemically, they were characterized by strong positivity for calretinin and epithelial markers. If a localized epididymal 
mass is found, it is necessary to conduct an adequate diagnostic examination to differentiate inflammatory process from 
the neoplasm. An excision of the lesion is the most recommended option that also preserves testicular function and fertil-
ity. Histological and immunohistochemical evaluation are mandatory for a definitive diagnosis.
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INTRODUCTION
The adenomatoid tumor of the epididymis is a rare 
benign neoplasm of mesothelial origin (Hes, 2003). 
Mostly it arises from the epididymis, but other tu-
mor localizations, such as the spermatic cord, testic-
ular tunica and ejaculatory ducts have been observed 
(Resinav and Carranzab, 2010). Adenomatoid tumor 
is  usually  presented  as  a  painless  scrotal  enlarge-
ment.  It  appears  as  a  circumscribed,  small,  solid, 
firm, white, yellow or brown nodule (Maestro, 2009). 
Immunohistochemically, it is characterized by strong 
positivity for calretinin and epithelial markers, while 
tumor marker values are within the reference ranges 
(Kontos, 2008).
Preoperative diagnostic procedures need to dis-
tinguishing between an adenomatoid tumor of the 
epididymis, infection or a testicular tumor, and when 
an  accurate  diagnosis  is  made,  the  recommended 
procedure that would also preserve testicular func-
tion is excision of the lesion (Amin and Parwani, 
2009).
MATERIAlS AND METHODS
We  present  the  first  case,  a  28-year-old  male, 
with no medical or surgical history of interest. A pa-
ratesticular  enlargement  was  accidentally  palpated 
during genito-scrotal examination performed for a 
penile rash. Both testes and penis were normal, but a 1042 D. KOJIĆ ET Al.
palpable indolent node was found in the right epidi-
dymis. Ultrasound imaging showed an inhomogene-
ous form 3 cm in diameter, mostly cystic on the up-
per pole of the epididymis.
Tumor markers, beta human chorionic gonado-
tropin (β-HCG), alpha-fetoprotein (AFP) and lac-
tate dehydrogenase (lDH), were in referent ranges, 
as  was  the  blood  count.  Microbiological  analysis 
showed the absence of sexually transmitted disease 
(STD). We performed excision of the tumor with 
preservation of the epididymis. It was a firm, inho-
mogeneous well-circumscribed mass, 30 x 18 x 12 
mm in size. Histopathological examination showed 
an adenomatoid tumor of the epididymis (Fig. 1A). 
Immunohistochemical  examination  found  tumor 
cells  diffusely  and  strongly  positive  for  CK  (AE1/
AE3)  and  calretinin,  and  negative  for  CD31  (Fig. 
1B-D). Twelve months after surgery the patient was 
asymptomatic, without local recurrence. 
The other patient was a 37-year-old male, mar-
ried,  with  two  children.  Several  years  before,  he 
noticed a small painless node on the lower pole of 
the right testis, which enlarged a few months before 
visiting  an  urologist.  Genito-scrotal  examination 
found both testes to be normal with the small, hard, 
indolent node on the lower pole of the right testis. 
Ultrasound showed small, confined, inhomogeneous 
tumor, 18.8 x 18.8 mm in size, on the right epidi-
dymis (Fig. 2). 
Tumor markers (AFP, β-HCG) were in the nor-
mal  range.  There  were  no  other  diseases,  genito-
scrotal infections or deviations in blood count. We 
performed excision of the tumor with epididymal 
preservation. Macroscopically it was a solid, whitish 
tumor.  Histopathological  examination  revealed  an 
adenomatoid tumor of the epididymis with similar 
characteristics to the previous case. After 6 months 
of follow-up, the patient was asymptomatic without 
any evidence of local recurrence.
RESUlTS AND DISCUSSION
Paratesticular tumors are rare forms, presenting less 
than  5-10%  of  intra-scrotal  neoplasms,  of  which 
70-80% are benign (Venyo, 2011). An adenomatoid 
tumor is a rare benign tumor of mesothelial origin 
that can be found in both female and male genital 
tracts. In females, the tumor is usually located in the 
myometrium, fallopian tubes or ovary hilus. More 
often it is found in males as an extratesticular mass, 
and it is one of the most common benign neoplasms. 
These tumors are more frequent in white males, and 
in most reported cases they were presented in pa-
tients in the third through fifth decades. Predomi-
nantly they are localized on the lower or upper pole 
of the epididymis, followed by the tunica vaginalis 
and spermatic cord (Evans, 2004).
Adenomatoid tumors are presented as either an 
incidental finding or a slow-growing scrotal mass. 
The usual form of presentation is a painless enlarge-
ment with normal scrotal skin and surrounding ad-
nexa. At the time of diagnosis, according to ultra-
sound and pathological studies, the most common 
diameter of a tumor is 2 to 5 cm. They are presented 
as circumscribed, small, solid, firm, grayish white 
nodules, although cystic cases were also identified 
(Maestro, 2009; Evans, 2004; Williams, 2004).
Histologically, three patterns of tumor have been 
recognized based on the epithelial cell arrangement: 
tubular, angiomatoid and plexiform. The adenoma-
toid (tubular) type is mainly characterized by glan-
dular structures, irregularly lined by cuboidal cells 
with vacuolated cytoplasm in certain cases, which 
resemble  signet  ring  cells.  The  angiomatoid  type 
consists of wide pseudovascular spaces, composed of 
flattened cells, scant cytoplasm, with an endothelial 
appearance. The solid (plexiform) type is formed of 
solid cords of cells with abundant, eosinophilic cyto-
plasm, with an epithelial-like appearance (Maestro, 
2009; Yazaki , 1976; Tavora, 2011).
Immunohistochemically, an adenomatoid tumor 
exhibits positivity for calretinin and epithelial mark-
ers, such as AE1/AE3, epithelial membrane antigen 
(EMA), Cam5.2, CK5/6, and CK7, by which their 
mesothelial origin is proved. CK5/6 and CK7 may 
be only focally positive. Endothelial markers, such EVAlUATION OF INDOlENT EPIDIDYMAl MASS – ADENOMATOID TUMOR OF THE EPIDIDYMIS 1043
fig. 1. Histopathological and immunohistochemical findings of the epididymal lesion showing: (A) an adenomatoid tumor of epididymis; 
tubular structures lined by attenuated cells infiltrate within fibrous and smooth muscle tissue. (B) Tumor cells positive for CK (AE1-
AE3). (C) Tumor cells showing positive immunostaining with calretinin. (D) Tumor cells negative for endothelial marker CD31.1044 D. KOJIĆ ET Al.
as factor VIII, CD31 and CD34, are negative (Hes, 
2003).  Referent  values  of  tumor  markers,  such  as 
β-HCG, AFP and lDH, help to exclude a malignant 
lesion (Delahunt, 2000; Sangoi, 2009).
Scrotal ultrasound is a useful imaging method to 
identify the lesion and differentiate it from testicular 
tumors. It may be hyper-echoic, iso-echoic, hypo-
echoic or it may adopt any morphology and does not 
show significant vascularity with color Doppler ex-
amination (Amin and Parwani, 2009). In addition, 
specific computed tomographic (CT) and magnetic 
resonance  imaging  (MRI)  can  be  performed,  and 
these findings, according to tumor localization, mor-
phology  and  tissue  characteristics  (attenuation  on 
CT and signal on MRI), can narrow the differential 
diagnosis (Barry, 2005; Patel, 2004).
Fine-needle aspiration biopsy (FNAB) is not a 
recommended  examination  because  of  possibility 
of tumor dissemination in a malignant lesion. Some 
authors performed extemporaneous biopsy in cases 
with intra-testicular tumor localization and doubt as 
to the malignant origin of the tumor (Mateu, 2010).
local excision of a lesion is an adequate treat-
ment, although some authors performed radical or-
chiectomy (tumor localization in testis) (Amin and 
Parwani, 2009; Alam and Maheshwari, 2011).
According to the recent literature data, few studies 
included analysis of numerous cases. In 2003, Chan-
dresekar et al. (2003) reported eight cases treated by 
excision of the tumor. localizations of the tumors 
varied: 5 were from the epididymis, 2 from the tunica 
albuginea and 1 from the testis. Maestro et al. (2009) 
published a report of nine cases of adenomatoid tu-
mor of which 7 were localized in the epididymis and 
2 on the testis. They performed seven removals of the 
mass and two radical orchiectomies. Similar results 
were presented by Gonzalez Resina et al. in a study 
of  nine  cases  with  adenomatoid  tumor  (Gonzalez 
fig. 2. Ultrasound scan showing a tumor on the right epididymis.EVAlUATION OF INDOlENT EPIDIDYMAl MASS – ADENOMATOID TUMOR OF THE EPIDIDYMIS 1045
Resina et al., 2010). All of them pointed out the im-
portance of valid diagnosis for minimal surgery with 
preserving testicular function (Maestro, 2009).
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